Find the latest pharmaceutical market place for APIs enquiry about Lifitegrast on PharmaCompass.com.

india-flag Flag

Lifitegrast API needed in India [ENA19887]

A company that focuses on development of comprehensive solutions in oral and parenteral drug delivery systems, analytical sciences, and pre-formulation studies is looking for suppliers of Lifitegrast API. The required quantity is 1 kg - 3 kg for development and 50 kg for commercial purposes. The suppliers must support this enquiry with USDMF & CoA.

Reply

05 Jul 2024

india-flag Flag

Lifitegrast API needed in India [ENA18792]

A CDMO that focuses on the research, development & manufacturing of tablets, capsules, creams, gels and sprays is looking for suppliers of Lifitegrast (2 kg - 5 kg) API for development purposes. The suppliers must support this enquiry with CoA.

Reply

20 Dec 2023

india-flag Flag

Lifitegrast (100 g) API needed in India [ENA14089]

A company that focuses in discovery, development, manufacturing and marketing a broad range of healthcare products is looking for suppliers of Lifitegrast (100 g) API for development purpose. The suppliers must support this enquiry with CoA.

Reply

24 Jun 2022

india-flag Flag

Various APIs needed in India [ENA10641]

A company specializing in analytical testing of a range of drug delivery systems is looking for Various APIs for development purposes. The required quantity is 50 g for each. The suppliers must support this enquiry with USDMF. The final market is the US.
1. USP Grade Brimonidine Tartrate API
2. Travoprost API
3. Timolol Maleate API
4. Budesonide (Sterile) API
5. Varenicline Tartrate API
6. Formoterol Fumarate API
7. Arformoterol Tartrate API
8. USP Grade Brinzolamide (Micronized) API
9. Loteprednol Etabonate API
10. Lifitegrast API
11. Naloxone Hydrochloride API

Reply

15 Jun 2021

Lifitegrast API needed in China [ENA05966]

A company focusing on research and development of generic drugs is looking for suppliers of Lifitegrast API. The supplier must support this enquiry with CoA.

Reply

06 Dec 2019

korearepublicofnew Flag

Perampanel, Metoclopramide & other APIs needed in Korea [ENA05440]

Rihu Healthcare, a leading value-added and multifunctional trader and distributor of pharmaceutical products, chemicals and functional health industries in Korea is looking for suppliers of below mentioned APIs. The supplier must support this enquiry with CoA and GMP. Interested suppliers can contact them via Email: justin.lim@rihuhealthcare.com.
1. Perampanel
2. Metoclopramide base
3. Brivaracetam
4. Lifitegrast
5. Cimetidine
6. Choline Chloride
7. Isolated Soy protein
8. Sodium Caseinate
9. Soybean Phospholipids
10. Calcium caseinate
11. Corn Oil

Reply

15 Oct 2019

Bangladesh Flag

Lifitegrast (2-5 kg) API needed in Bangladesh [ENA04760]

One of the fastest growing indenting company based in Bangladesh providing quality services is looking for suppliers of Lifitegrast (2-5 kg) API. The supplier must support this enquiry with the following documentations:
1. CoA
2. MoA
3. MSDS
4. GMP
5. DMF.

Reply

30 Jul 2019

USP/EP grade Miglustat and Lifitegrast APIs needed in Iran [ENA04551]

A generic developing company mainly dealing in injectables, solid dosage forms and sterile drops is looking for suppliers of USP/EP grade Miglustat and Lifitegrast APIs.

Reply

04 Jul 2019

Bangladesh Flag

Lifitegrast (Sterile) API needed in Bangladesh [ENA02291]

ASN corporation- a prominent and leading Trading Company in Bangladesh, engaged in sales and marketing of Pharmaceutical Packing Materials & Raw Materials (API’s), Intermediates, Excipients, Vitamins, Flavors, Coating materials etc is looking for suppliers of Lifitegrast (Sterile) API. Interested suppliers must support this enquiry with Certificate of Analysis (COA), a valid GMP Certificate.

Reply

13 Oct 2018

Enquiry// Lifitegrast API needed in Colombia [ENA00873]

A Colombia based manufacturing and commercializing company of specialized pharmaceutical forms, located in the city of Barranquilla is searching for suppliers of Lifitegrast API for domestic consumption.

Reply

01 May 2018